Bristol-Myers Squibb Co. (BMY) PT Lowered to $51 at BofA/Merrill Lynch

February 19, 2019 6:33 AM EST Send to a Friend

BofA/Merrill Lynch analyst Jason Gerberry lowered ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Bristol-Myers Squibb Co. (BMY) PT Lowered to $51 at BofA/Merrill Lynch

Member Login

Free News Feed